Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

P
Pérez-Velasco, Rocío

Hospital Universitario Virgen del Rocio
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
Rocío Pérez-Velasco
Favorite
Pablik, Jessica

Department of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Jessica Pablik
Favorite
Padilla, Catarina

The Netherlands Cancer Institute
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Catarina Padilla
Favorite
Padilla, Karen

Texas Tech University Health Science Center El Paso
(P 78) MENTAL HEALTH DISORDERS FOLLOWING PATHOLOGICAL FRACTURE: A RETROSPECTIVE COHORT STUDY
Karen Padilla
Favorite
Paglia, Simona

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Simona Paglia
Favorite
Pagnoni, Chiara

Fondazione Policlinico Universitario Campus Bio-Medico
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Chiara Pagnoni
Favorite
Paisan, Ana

Hospital Universitario Donostia
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Ana Paisan
Favorite
Palassini, Elena

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Elena Palassini
Favorite
Palassini, Elena

Fondazione IRCCS Istituto Nazionale Tumori
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Elena Palassini
Favorite
Paley, Lizz

National Disease Registration Service, NHS England
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Lizz Paley
Favorite
Palmerini, Emanuela

Sylvester Comprehensive Cancer Center
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Emanuela Palmerini
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Emanuela Palmerini
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Emanuela Palmerini
Favorite
(P 403) MEDICAL MANAGEMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Emanuela Palmerini
Favorite
Palova Jelinkova, Lenka

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Lenka Palova Jelinkova
Favorite
Pal, Rahul

Mass Eye and Ear
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Rahul Pal
Favorite
Pan, Dean

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Dean Pan
Favorite
Pandey, Rambha

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Rambha Pandey
Favorite
Pandey, Saurav

Boston Children's Hospital Department of Orthopaedic Surgery
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Saurav Pandey
Favorite
Panjwani, Poonam

Tata Memorial Hospital
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Poonam Panjwani
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Poonam Panjwani
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Poonam Panjwani
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Poonam Panjwani
Favorite
Pan, Minggui

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Minggui Pan
Favorite
(P 297) ANALYSIS OF CTDNA KINETICS IN PATIENTS WITH METASTATIC LEIOMYOSARCOMA UNDERGOING LOCOREGIONAL PROCEDURAL INTERVENTION
Minggui Pan
Favorite
Pannucci, Abbe

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Abbe Pannucci
Favorite
Pantaleo, Maria Abbondanza

Oncology Unit. Department of Medical and Surgical Sciences, University of Bologna
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Maria Abbondanza Pantaleo
Favorite
Pantano, Francesco

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Francesco Pantano
Favorite
Pan, Yutong

The University of Texas Health Science Center at Houston
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Yutong Pan
Favorite
Papadopoulos, Kyriakos P.

START San Antonio
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Kyriakos P. Papadopoulos
Favorite
Papinska, Anna

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Anna Papinska
Favorite
Papke, David

Brigham and Women's Hospital
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
David Papke
Favorite
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
David Papke
Favorite
Paralkar, Vishwas

Cybrexa Therapeutics
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Vishwas Paralkar
Favorite
parambil, badira

Tata Memorial Hospital
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
badira parambil
Favorite
Paratala, Bhavna

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Bhavna Paratala
Favorite
Parker, Dominique

Vanderbilt University
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Dominique Parker
Favorite
Park, Hyenmin

National Cancer Center
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Hyenmin Park
Favorite
Park, Jay Hoon

Department of Orthopaedic surgery, Seoul National University Hospital
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Jay Hoon Park
Favorite
Park, Jong Woong

National Cancer Center
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
Jong Woong Park
Favorite
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Jong Woong Park
Favorite
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Jong Woong Park
Favorite
Parolia, Abhijit

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Abhijit Parolia
Favorite
Parra, Tabita

Instituto Traumatologico Teodoro Gebauer
(P 212) MISINFORMATION IN SARCOMA CONTENT ON SOCIAL MEDIA PLATFORMS
Tabita Parra
Favorite
Parry, Michael

Royal Orthopaedic Hospital Birmingham
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Michael Parry
Favorite
Parsons, Katelyn

Duke University School of Medicine
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Katelyn Parsons
Favorite
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Katelyn Parsons
Favorite
Pasqualini, Ignacio

Cleveland Clinic
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Ignacio Pasqualini
Favorite
Pasquali, Sandro

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Sandro Pasquali
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Sandro Pasquali
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Sandro Pasquali
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Sandro Pasquali
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Sandro Pasquali
Favorite
Pastorino, Ugo

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Ugo Pastorino
Favorite
Patel, Kirtan

Stanley Manne Children's Research Institute
(P 252) NUCLEAR AND GENOMIC ORGANIZATION OF CHEMOTHERAPY RESISTANT RHABDOMYOSARCOMA CELLS
Kirtan Patel
Favorite
Patel, Rishi

University of Iowa Health Care
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Rishi Patel
Favorite
Patel, Rudra

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Rudra Patel
Favorite
Patel, Rutulkumar

M.D. Anderson Cancer Center, University of Texas
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Rutulkumar Patel
Favorite
Patel, Shreyaskumar

University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Shreyaskumar Patel
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Shreyaskumar Patel
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Shreyaskumar Patel
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Shreyaskumar Patel
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Shreyaskumar Patel
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Shreyaskumar Patel
Favorite
Paternostro, Flavia

Università Campus Bio-medico Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Flavia Paternostro
Favorite
Patil, Vasundhara

Tata Memorial Hospital, Tata memorial Centre, Mumbai
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Vasundhara Patil
Favorite
Patkar, Shraddha

Tata Memorial Hospital, Mumbai, India
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Shraddha Patkar
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Shraddha Patkar
Favorite
Patt, Joshua

Atrium Health Levine Cancer Institute
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Joshua Patt
Favorite
Paudel, Amrit

University of Miami/Sylvester Comprehensive Cancer Center
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Amrit Paudel
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Amrit Paudel
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Amrit Paudel
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Amrit Paudel
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Amrit Paudel
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Amrit Paudel
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Amrit Paudel
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Amrit Paudel
Favorite
Pavisic, Jovana

Memorial Sloan Kettering Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Jovana Pavisic
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Jovana Pavisic
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jovana Pavisic
Favorite
Peairs, Emily

Mayo Clinic
(P 96) AMPUTATION FOLLOWING MEGAPROSTHESIS USE IN LIMB SALVAGE
Emily Peairs
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Emily Peairs
Favorite
(P 348) SYNOVIAL SARCOMA INVOLVING NERVES: HIGH RATE OF MISIDENTIFICATION AS BENIGN TUMORS
Emily Peairs
Favorite
Pearce, Hayes

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Hayes Pearce
Favorite
Pelster, Meredith

Sarah Cannon Research Institute
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Meredith Pelster
Favorite
Pemmanda, Mira

St John’s School
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Mira Pemmanda
Favorite
Penel, Nicolas

Centre Oscar Lambret
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Nicolas Penel
Favorite
Pennacchioli, Elisabetta

European Institute of Oncology, IRCCS
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Elisabetta Pennacchioli
Favorite
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Elisabetta Pennacchioli
Favorite
Penrose, Andrea

Northwestern Medicine
(P 353) TREATMENT OF ADVANCED EPITHELIOID SARCOMA WITH COMBINATION TAZEMETOSTAT AND PEMBROLIZUMAB
Andrea Penrose
Favorite
Perati, Shruthi

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Shruthi Perati
Favorite
Percio, Stefano

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Stefano Percio
Favorite
Pereira, Caio

Hospital de Amor
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Caio Pereira
Favorite
Pereira, Janice

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Janice Pereira
Favorite
Peretz Soroka, Hagit

Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) - Princess Margaret Cancer Centre
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Hagit Peretz Soroka
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Hagit Peretz Soroka
Favorite
Perez Plasencia, Carlos

Universidad Nacional Autonoma de Mexico
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Carlos Perez Plasencia
Favorite
PEREZ YEPEZ, ELOY

Instituto Nacional de Cancerología
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
ELOY PEREZ YEPEZ
Favorite
Perez, Juan Esteban

University of Pennsylvania
(P 185) CANCER TESTIS ANTIGENS AS TARGETS IN KIT11-MUTATED, IMATINIB-RESISTANT GIST
Juan Esteban Perez
Favorite
Perez, Melanie

Duke University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Melanie Perez
Favorite
Perkins, Callum

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Callum Perkins
Favorite
Perot, Gaelle

INSERM
(P 28) ADVANCING PRECISION ONCOLOGY IN SOFT TISSUE SARCOMAS: THE ROLE OF ITRAC IN METASTATIC RISK STRATIFICATION AND TREATMENT PERSONALIZATION
Gaelle Perot
Favorite
Perret, Raul

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Raul Perret
Favorite
Perrotta, Amanda

David Geffen School of Medicine at University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Amanda Perrotta
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Amanda Perrotta
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Amanda Perrotta
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Amanda Perrotta
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Amanda Perrotta
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Amanda Perrotta
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Amanda Perrotta
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Amanda Perrotta
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Amanda Perrotta
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Amanda Perrotta
Favorite
Pesenti, Anita

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Anita Pesenti
Favorite
Pesic, Dusan

The Hospital for Sick Children (SickKids)
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Dusan Pesic
Favorite
Peters, Haley

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Haley Peters
Favorite
Petrova, Boryana

Boston Children's Hospital
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Boryana Petrova
Favorite
PEYRAUD, FLORENT

INSTITUT BERGONIE
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
FLORENT PEYRAUD
Favorite
Philippon, Marc

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Marc Philippon
Favorite
Phua, Brandon Xuan Ming

A*STAR Bioinformatics Institute (BII)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Brandon Xuan Ming Phua
Favorite
Pianykh, Oleg

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Oleg Pianykh
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Oleg Pianykh
Favorite
Piao, Zhegao

Department of Artificial Intelligence and Data Science, Sejong University, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Zhegao Piao
Favorite
Piatkowski, Jakub

Institute of Genetics and Biology, Faculty of Biology, University of Warsaw
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Jakub Piatkowski
Favorite
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Jakub Piatkowski
Favorite
Piatkowski, Jakub

University of Warsaw
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Jakub Piatkowski
Favorite
Picarsic, Jennifer

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jennifer Picarsic
Favorite
Pienkowski, Andrzej

Maria Sklodowska-Curie National Research Institute of Oncology
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Andrzej Pienkowski
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Andrzej Pienkowski
Favorite
Pierce, Andrew

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Andrew Pierce
Favorite
Pierini, Michela

IRCCS Istituto Ortopedico Rizzoli
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Michela Pierini
Favorite
Pignoli, Emanuele

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Emanuele Pignoli
Favorite
Piha-Paul, Sarina A.

University of Texas MD Anderson Cancer Center
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Sarina A. Piha-Paul
Favorite
Pikabea, Fernando

Hospital Universitario Basurto
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Fernando Pikabea
Favorite
Pilar, Avinash

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Avinash Pilar
Favorite
Pino, Lindsay

TalusBio
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Lindsay Pino
Favorite
Piotrowska, Zofia

Massachusetts General Hospital
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Zofia Piotrowska
Favorite
Placzke, Joanna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Joanna Placzke
Favorite
Pollack, Seth

Northwestern University Feinberg School of Medicine
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Seth Pollack
Favorite
(P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.
Seth Pollack
Favorite
(P 353) TREATMENT OF ADVANCED EPITHELIOID SARCOMA WITH COMBINATION TAZEMETOSTAT AND PEMBROLIZUMAB
Seth Pollack
Favorite
(P 373) COMPLETE RESPONSE TO FRONT-LINE PEXIDARTINIB IN SYMPTOMATIC TEMPOROMANDIBULAR JOINT TENOSYNOVIAL GIANT CELL TUMOR
Seth Pollack
Favorite
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Seth Pollack
Favorite
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Seth Pollack
Favorite
Pollock, Brad

University of California Davis
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Brad Pollock
Favorite
Polymeropoulos, Alessio

Fondazione IRCCS Istituto Nazionale Tumori
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Alessio Polymeropoulos
Favorite
Ponzoni, Adele

Center for Discovery and Innovation, Hackensack Meridian Health
(P 251) SPATIAL MULTI-OMIC ANALYSIS OF RHABDOMYOSARCOMA IDENTIFIES THERAPEUTIC VULNERABILITIES
Adele Ponzoni
Favorite
Potter, Samara

Institute for Genomic Medicine, Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Samara Potter
Favorite
Powell, Andrece

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Andrece Powell
Favorite
(P 401) LONG-TERM OUTCOMES OF IMATINIB-TREATED DERMATOFIBROSARCOMA PROTUBERANS: INSIGHTS FROM A SINGLE-INSTITUTION CASE SERIES
Andrece Powell
Favorite
Powers, Benjamin

The University of Kansas Health System
(P 354) UNEXPECTED RESPONSE TO ERIBULIN IN A REFRACTORY LEIOMYOSARCOMA PATIENT WITH HEREDITARY P53 MUTATION
Benjamin Powers
Favorite
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Benjamin Powers
Favorite
Poysungnoen, August

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
August Poysungnoen
Favorite
Pozas, Javier

University College London Hospitals
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Javier Pozas
Favorite
Pradhan, Nikash

University of Iowa Hospitals and Clinics
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
Nikash Pradhan
Favorite
Prado, Juliano

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Juliano Prado
Favorite
Prasad, Maya

Tata Memorial Hospital
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Maya Prasad
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Maya Prasad
Favorite
Pratilas, Christine

Johns Hopkins University
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Christine Pratilas
Favorite
Pressey, Joseph

University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Joseph Pressey
Favorite
Primo Basílio de Souza, Viviane

AC Camargo Cancer Center
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Viviane Primo Basílio de Souza
Favorite
Pruthi, Manish

Tata Memorial Hospital
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
Manish Pruthi
Favorite
(P 208) TRANSLATION, CROSS CULTURAL ADAPTATION AND VALIDATION OF TESS IN REGIONAL INDIAN LANGUAGES WITH ~500 MILLION GLOBAL DIASPORA
Manish Pruthi
Favorite
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Manish Pruthi
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Manish Pruthi
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Manish Pruthi
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Manish Pruthi
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Manish Pruthi
Favorite
przybojewski, Stefan

Foothills Medical Center
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Stefan przybojewski
Favorite
Przybyl, Joanna

McGill University
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Joanna Przybyl
Favorite
Pulivendala, Gauthami

University of Miami
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
Gauthami Pulivendala
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Gauthami Pulivendala
Favorite
Pullanhi, Anoopa

Sultan Qaboos Comprehensive Cancer Care and Research Center - University Medical City
(P 56) COMPARISON OF PATHOGENIC AND LIKELY PATHOGENIC VARIANTS DISTINCT FROM SPECIFIC DRIVERS IN DIFFERENT SARCOMA GROUPS
Anoopa Pullanhi
Favorite
Puntis, Nic

GIST CANCER UK
(P 202) TRAVEL GRANT
Nic Puntis
Favorite
Purandare, Nilendu

Tata Memorial Hospital, Mumbai
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Nilendu Purandare
Favorite
Puri, Ajay

Tata Memorial Hospital
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
Ajay Puri
Favorite
Puri, Ajay

TATA Memorial Centre
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Ajay Puri
Favorite
Puri, Ajay

Tata Memorial Hospital
(P 208) TRANSLATION, CROSS CULTURAL ADAPTATION AND VALIDATION OF TESS IN REGIONAL INDIAN LANGUAGES WITH ~500 MILLION GLOBAL DIASPORA
Ajay Puri
Favorite
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Ajay Puri
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Ajay Puri
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Ajay Puri
Favorite
Purl, Megan

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Megan Purl
Favorite
Purohit, Rashi

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Rashi Purohit
Favorite
Pusztai, Ada

LMU Munich
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Ada Pusztai
Favorite
Puviindran, Vijitha

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Vijitha Puviindran
Favorite
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Vijitha Puviindran
Favorite